Literature DB >> 16884708

Mitochondrial P450s.

Tsuneo Omura1.   

Abstract

Cytochrome P450 was first found in the microsomes from animal tissues, and then the presence of P450 in mitochondria was reported for the steroidogenic organs, adrenal gland and gonads. Three forms of mitochondrial P450 (11A, 11B1, and 11B2) were purified from these organs and their functions in steroid hormone biosynthesis were confirmed. Later studies showed the presence of several other forms of P450 (24A, 27A, 27B, and 27C) in the mitochondria of various non-steroidogenic organs including liver and kidney. These mitochondrial P450s were found to participate in the biosynthesis of bile acids from cholesterol in the liver, and the metabolic activation of Vitamin D3 to its active form, 1,25-dihydroxyvitamin D3, in the liver and the kidney. In contrast to the "drug-metabolizing" P450s in microsomes, most mitochondrial P450s show high specificity to their endogenous substrates, and have negligible activity towards xenobiotic compounds. In contrast to these established roles of mitochondrial P450s in the metabolism of endogenous substrates, the metabolism of xenobiotic chemicals by P450-catalyzed reactions in mitochondria has long been a subject of controversy. It is now known that all P450s in eukaryotic organisms are coded by nuclear genes, and the nascent peptides of various forms of P450 synthesized by cytoplasmic ribosomes are targeted to either endoplasmic reticulum (ER) or mitochondria depending on the ER-targeting sequence or the mitochondria-targeting sequence present in their amino-terminal portion. However, the presence of some microsome-type P450s in the mitochondria from various animal tissues including liver and brain has been reported. Possible mechanisms of intracellular sorting of some microsome-type P450s to mitochondria have been proposed, although physiological significance of the contribution of P450s in mitochondria to the metabolism of xenobiotic chemicals in animal tissues is still elusive.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16884708     DOI: 10.1016/j.cbi.2006.06.008

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  32 in total

1.  Biomedical Technologies for in vitro Screening and Controlled Delivery of Neuroactive Compounds.

Authors:  John P Frampton; Michael L Shuler; William Shain; Matthew R Hynd
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2008

2.  Quantification of cholesterol-metabolizing P450s CYP27A1 and CYP46A1 in neural tissues reveals a lack of enzyme-product correlations in human retina but not human brain.

Authors:  Wei-Li Liao; Gun-Young Heo; Nathan G Dodder; Rachel E Reem; Natalia Mast; Suber Huang; Pier Luigi Dipatre; Illarion V Turko; Irina A Pikuleva
Journal:  J Proteome Res       Date:  2010-11-16       Impact factor: 4.466

Review 3.  Bimodal targeting of microsomal cytochrome P450s to mitochondria: implications in drug metabolism and toxicity.

Authors:  Michelle C Sangar; Seema Bansal; Narayan G Avadhani
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-10       Impact factor: 4.481

4.  Conservation of the Enzyme-Coenzyme Interfaces in FAD and NADP Binding Adrenodoxin Reductase-A Ubiquitous Enzyme.

Authors:  Israel Hanukoglu
Journal:  J Mol Evol       Date:  2017-11-24       Impact factor: 2.395

Review 5.  Clinical effects of chemical exposures on mitochondrial function.

Authors:  Zarazuela Zolkipli-Cunningham; Marni J Falk
Journal:  Toxicology       Date:  2017-07-27       Impact factor: 4.221

Review 6.  Bimodal targeting of cytochrome P450s to endoplasmic reticulum and mitochondria: the concept of chimeric signals.

Authors:  Narayan G Avadhani; Michelle C Sangar; Seema Bansal; Prachi Bajpai
Journal:  FEBS J       Date:  2011-10-24       Impact factor: 5.542

Review 7.  Adaptive evolution of mammalian aromatases: lessons from Suiformes.

Authors:  A J Conley; C J Corbin; A L Hughes
Journal:  J Exp Zool A Ecol Genet Physiol       Date:  2009-06-01

8.  Mitochondrial P450-dependent arachidonic acid metabolism by TCDD-induced hepatic CYP1A5; conversion of EETs to DHETs by mitochondrial soluble epoxide hydrolase.

Authors:  Erin M Labitzke; Silvia Diani-Moore; Arleen B Rifkind
Journal:  Arch Biochem Biophys       Date:  2007-08-25       Impact factor: 4.013

9.  Studies of membrane topology of mitochondrial cholesterol hydroxylases CYPs 27A1 and 11A1.

Authors:  Irina A Pikuleva; Natalia Mast; Wei-Li Liao; Illarion V Turko
Journal:  Lipids       Date:  2008-09-13       Impact factor: 1.880

10.  Cholesterol effects on BAX pore activation.

Authors:  Eric Christenson; Sean Merlin; Mitsu Saito; Paul Schlesinger
Journal:  J Mol Biol       Date:  2008-06-20       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.